Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, Mawatari K, Yasukawa H, Kaida H, Ishibashi M, Hayabuchi N, Harada H, Ikeda H, Yamagishi S, Imaizumi T. Mizoguchi M, et al. JACC Cardiovasc Imaging. 2011 Oct;4(10):1110-8. doi: 10.1016/j.jcmg.2011.08.007. JACC Cardiovasc Imaging. 2011. PMID: 21999871 Free article. Clinical Trial.
Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography.
Tahara N, Yamagishi S, Takeuchi M, Honda A, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Matsui T, Imaizumi T. Tahara N, et al. Among authors: mizoguchi m. Diabetes Care. 2012 Dec;35(12):2618-25. doi: 10.2337/dc12-0087. Epub 2012 Aug 21. Diabetes Care. 2012. PMID: 22912424 Free PMC article.
Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Baba K, Ishibashi M, Hayabuchi N, Narula J, Imaizumi T. Tahara N, et al. Among authors: mizoguchi m. JACC Cardiovasc Imaging. 2010 Dec;3(12):1219-28. doi: 10.1016/j.jcmg.2010.09.015. JACC Cardiovasc Imaging. 2010. PMID: 21163450 Free article.
Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
Kodama N, Tahara N, Tahara A, Honda A, Nitta Y, Mizoguchi M, Kaida H, Ishibashi M, Abe T, Ikeda H, Narula J, Fukumoto Y, Yamagishi S, Imaizumi T. Kodama N, et al. Among authors: mizoguchi m. J Clin Endocrinol Metab. 2013 Nov;98(11):4438-45. doi: 10.1210/jc.2013-2920. Epub 2013 Sep 12. J Clin Endocrinol Metab. 2013. PMID: 24030946 Clinical Trial.
Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y, Tahara N, Tahara A, Honda A, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Ikeda H, Yamagishi S, Imaizumi T. Nitta Y, et al. Among authors: mizoguchi m. JACC Cardiovasc Imaging. 2013 Nov;6(11):1172-82. doi: 10.1016/j.jcmg.2013.09.004. JACC Cardiovasc Imaging. 2013. PMID: 24229770 Free article. Clinical Trial.
Long-term treatment with valsartan improved cyclic variation of the myocardial integral backscatter signal and diastolic dysfunction in hypertensive patients: the echocardiographic assessment.
Mizuta Y, Kai H, Mizoguchi M, Osada K, Tahara N, Nakaura H, Kuwahara F, Imaizumi T; Valsartan Diastolic Function Improvement Study Investigators. Mizuta Y, et al. Among authors: mizoguchi m. Hypertens Res. 2008 Oct;31(10):1835-42. doi: 10.1291/hypres.31.1835. Hypertens Res. 2008. PMID: 19015589 Clinical Trial.
494 results